Abstract
The State of Kidney Failure in the United States in 2018
Highlights
Private insurance companies typically reimburse dialysis organizations at a significantly higher rate than Medicare or Medicaid
JOJ uro & nephron Copyright © All rights are reserved by John D Sullivan
The government grossly underestimated the future cost of this program, since it assumed that most patients who are medically suitable for dialysis are under age 54 with few if any comorbidities and that only one in five End Stage Renal Disease (ESRD) patients are eligible for dialysis
Summary
Private insurance companies typically reimburse dialysis organizations at a significantly higher rate than Medicare or Medicaid. JOJ uro & nephron Copyright © All rights are reserved by John D Sullivan End Stage Renal Disease (ESRD) impacts the lives of over 700,000 American patients (including transplant recipients) and their families and costs United States taxpayers approximately $32.8 billion in annual Medicare expenditures.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
